A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
2016; DABIGATRAN was indexed under BENZIMIDOAZOLES and BETA-ALANINE 2010-2015; DABIGATRAN ETEXILATE was indexed under BENZIMIDOAZOLES and PYRIDINES 2002-2015
A THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.